Greater Cannabis Company Inc (GCAN)

[SPecPrototype]

Dr. Hock Tan had this to say, “I am delighted to be part of the Greater Cannabis Company. My career has always been focused on bringing breakthrough technologies out from the lab and into industry where they can make a difference in people’s lives. I was inspired by what Greater Cannabis is setting out to do with the eluting patch technology. The technology is more unique than is apparent at the surface level, and I think the Company will do a great job at showing what it is truly capable of through Cannabinoid applications.”

About Dr. Hock Tan, Ph.D.
Hock S. Tan, PhD, is the founder/principal of Bionex Pharmaceuticals LLC. Dr. Tan has 20 years of experience in pharmaceutical product development, with expertise in drug delivery systems. His career spans over a broad range of areas including R&D, business development, project management, cGMP clinical supply manufacturing, and product commercialization. Under his leadership, Bionex received four Small Business Innovation Research (SBIR) awards. He has worked for and with companies such as Johnson & Johnson, Novartis, Abbott and Xerox Corporation. Dr. Tan has developed proprietary formulations, delivery technologies, and products related to medical and skin care applications. He has led thin film drug development for different applications such as post-surgical indications for pain reduction, infection control, wound healing, and tissue adhesion prevention. For example, PLGA implant film, drug-coated/drug-loaded sutures, and hemostat device carrying drugs. Dr. Tan has invented and filed patent applications on novel film-fabric construct to deliver pain reduction agents, and has developed in vitro and in vivo drug-release test methods. He holds a Ph.D. in chemical engineering, and has authored eight issued U.S. patents and multiple peer reviewed articles.